Expression of thromboxane synthase in kidney tissues from patients with IgA nephropathy

Clinical Nephrology

Volumn 47, Issue 3, 1997, Pages 168-175

  Endoh, M ^a   Kashem, A ^a   Yamauchi, F ^a   Yano, N ^a   Nomoto, Y ^a   Sakai, H ^a   Kurokawa, K ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Glomerulonephritis; Macrophage; Renal function; Thromboxane

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; MESSENGER RNA; THROMBOXANE A2; THROMBOXANE SYNTHASE; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MACROPHAGE; MONOCYTE; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BETA 2-MICROGLOBULIN; CREATININE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; RNA, MESSENGER; THROMBOXANE A2; THROMBOXANE-A SYNTHASE;

EID: 0030997103     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Alamanine E, Sabatier JC, Berthoux FC 1990 Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis. Clin Nephrol 34: 45-51
2. Arima S, Nakayama M, Naito M, Sato T, Takahashi K 1991 Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 39: 684-692
3. Baylis C 1987 Effects of administered thromboxanes on the intact, normal rat kidney. Renal Physiol 10: 1110-1121
4. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR 1992 Vascular permeability factor (vascular endothelial growth factor gene) is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3: 211-220
5. Bogenschutz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Ganner HV 1990 IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 10: 137-147
6. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, Rosen S 1992 Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42: 1457-1461
7. Cameron JS 1992 Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr Nephrol 6: 292-303
8. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenole-chloroform extraction. Anal Biochem 762: 156-159
9. Feiner H D, Cabili S, Baldwin DS, Schacht RG, Gallo GR 1982 Intrarenal vascular sclerosis in IgA nephropathy. Clin Nephrol 18: 183-192
10. Funabiki K, Horikoshi S, Tomino Y, Nagai Y, Koide H 1990 Immuno-histochemical analysis of extracellular components in the glomerular sclerosis of patients with glomerulonephritis. Clin Nephrol 14:239-246
11. Gesualdo L, Di Paoto S, Milani S, Pinzani M, Grappone C, Ranieri E, Pannarale G, Schena FP 1994 Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J Clin Invest 94: 50-58
12. Horii Y, Muraguchi Y, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoio Y, Yoshizaki K, Hirano T, Kishimoto T 1989 Involvement of interieukin-6 in mesangial proiiferative glomerulonephritis. J Immunol 143: 3949-3955
13. Kelley VE, Sneve S, Musinski S 1986 Increased renal thromboxane production in murine lupus nephritis. J Clin Invest 77: 252-259
14. Llanos EA, Andres GA, Dunn MJ 1983 Glomerular prostagiandin and thromboxane synthesis in rat nephrotoxic serum nephritis. J Clin Invest 72: 1439-1448
15. Nagata M, Akioka Y, Tsunoda Y, Komatsu Y, Kawaguchi H, Yamagichi Y, Ito K 1995 Macrophages in childhood IgA nephropathy. Kidney Int 48: 521-535
16. Niwa T, Maeda K, Shibata M. Yanada K 1988 Clinical effects of selective thromboxane A2 synthase inhibitor in patients with nephrotic syndrome. Clinical Nephrol 30: 276-281
17. Nomoto Y, Endoh M, Suga T, Miura M, Sakai H 1992 Minimum requirements for renal biopsy size for patients with IgA nephropathy. Nephron 60: 171-175
18. Nomoto Y, Tomino Y, Endoh M, Suga T, Miura M, Nomoto H, Sakai H 1987 Modified open renal biopsy: Results in 934 patients. Nephron 45: 224-228
19. Nusing R, Wernet MP, Ullrich V 1990 Production and characterization of polyclonal and monoclonal antibodies against human thromboxane synthase. Blood 76: 80-85
20. Owada A, Tomita K, Terada Y, Sakamoto H, Nonoguchi H, Marumo F 1994 Endothelin(ET)-3 stimulates cyclic guanosine 3′, 5′-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus and in cultured mesangial cells. J Clin Invest 93: 556-563
21. Pierucci A, Simonetti BM, Pecci G, Mavrikakis G, Feriozzi S, Cinotti GA, Pathgnani P, Ciabattoni G, Patrono C 1989 Improvement of renal function with selective thromboxane antagonism in lupus nephritis. New Engl J Med 320: 421-425
22. Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, Klahr A 1985 Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 82: 193-197
23. Remuzzi G, Imberii L, Rossini M, Morelli C, Carminati C, Cattaneo GM, Bertani T 1985 Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. J Clin Invest 75: 94-101
24. Rifai A, Sakai H, Yagame M 1993 Expression of 5-lipoxygenase and 5-lipoxygenase activation protein in glomerulonephritis. Kidney IntSuppl 39:595-99
25. Stahl RA, Thaiss F, Kahf S, Schoeppe W, Helmchen UM 1990 Immunemediated mesangial cell injury - biosynthesis and function of prostanoids. Kidney Int 38: 273-281
26. Wilcox CS, Folger WH, Welch WJ 1994 Renal vasoconstriction with U-46,619: Role of arachidonate metabolites. J Am Soc Nephrol 5: 1120-1124